Stockreport

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF Full imaging and dosimetry data from MP0712 compassionate care program to be presented at TWC 2026 Phase 2 investigator-initiated trial of MP0317 now open with patien [Read more]